Fingerprint
Dive into the research topics of 'Phase II trial of nolatrexed dihydrochloride [Thymitaq™, AG 337] in patients with advanced hepatocellular carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of nolatrexed dihydrochloride [Thymitaq™, AG 337] in patients with advanced hepatocellular carcinoma
Minaxi Jhawer, Lee Rosen, Janet Dancey, Howard Hochster, Solomon Hamburg, Margaret Tempero, Neil Clendeninn, Sridhar Mani
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations